Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $24.81 billion. The enterprise value is $20.99 billion.
| Market Cap | 24.81B |
| Enterprise Value | 20.99B |
Important Dates
The last earnings date was Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 203.83 million shares outstanding. The number of shares has increased by 3.21% in one year.
| Current Share Class | 203.83M |
| Shares Outstanding | 203.83M |
| Shares Change (YoY) | +3.21% |
| Shares Change (QoQ) | -2.39% |
| Owned by Insiders (%) | 0.46% |
| Owned by Institutions (%) | 86.48% |
| Float | 171.56M |
Valuation Ratios
The trailing PE ratio is 62.60 and the forward PE ratio is 15.44. Incyte's PEG ratio is 1.42.
| PE Ratio | 62.60 |
| Forward PE | 15.44 |
| PS Ratio | 4.13 |
| Forward PS | 4.11 |
| PB Ratio | 4.40 |
| P/TBV Ratio | 4.59 |
| P/FCF Ratio | 36.22 |
| P/OCF Ratio | 33.30 |
| PEG Ratio | 1.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.31, with an EV/FCF ratio of 30.65.
| EV / Earnings | 52.03 |
| EV / Sales | 3.49 |
| EV / EBITDA | 10.31 |
| EV / EBIT | 10.84 |
| EV / FCF | 30.65 |
Financial Position
The company has a current ratio of 3.84, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.84 |
| Quick Ratio | 3.54 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.05 |
| Interest Coverage | 828.46 |
Financial Efficiency
Return on equity (ROE) is 7.84% and return on invested capital (ROIC) is 53.44%.
| Return on Equity (ROE) | 7.84% |
| Return on Assets (ROA) | 17.78% |
| Return on Invested Capital (ROIC) | 53.44% |
| Return on Capital Employed (ROCE) | 33.11% |
| Weighted Average Cost of Capital (WACC) | 8.55% |
| Revenue Per Employee | $2.11M |
| Profits Per Employee | $141,846 |
| Employee Count | 2,844 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 24.29 |
Taxes
In the past 12 months, Incyte has paid $392.80 million in taxes.
| Income Tax | 392.80M |
| Effective Tax Rate | 49.33% |
Stock Price Statistics
The stock price has increased by +12.52% in the last 52 weeks. The beta is 0.78, so Incyte's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +12.52% |
| 50-Day Moving Average | 119.32 |
| 200-Day Moving Average | 108.82 |
| Relative Strength Index (RSI) | 55.75 |
| Average Volume (20 Days) | 1,785,895 |
Short Selling Information
The latest short interest is 10.65 million, so 5.22% of the outstanding shares have been sold short.
| Short Interest | 10.65M |
| Short Previous Month | 10.03M |
| Short % of Shares Out | 5.22% |
| Short % of Float | 6.21% |
| Short Ratio (days to cover) | 5.61 |
Income Statement
In the last 12 months, Incyte had revenue of $6.01 billion and earned $403.41 million in profits. Earnings per share was $1.94.
| Revenue | 6.01B |
| Gross Profit | 3.37B |
| Operating Income | 1.94B |
| Pretax Income | 796.21M |
| Net Income | 403.41M |
| EBITDA | 2.04B |
| EBIT | 1.94B |
| Earnings Per Share (EPS) | $1.94 |
Balance Sheet
The company has $3.85 billion in cash and $37.41 million in debt, with a net cash position of $3.82 billion or $18.73 per share.
| Cash & Cash Equivalents | 3.85B |
| Total Debt | 37.41M |
| Net Cash | 3.82B |
| Net Cash Per Share | $18.73 |
| Equity (Book Value) | 5.64B |
| Book Value Per Share | 27.66 |
| Working Capital | 4.08B |
Cash Flow
In the last 12 months, operating cash flow was $744.99 million and capital expenditures -$60.12 million, giving a free cash flow of $684.87 million.
| Operating Cash Flow | 744.99M |
| Capital Expenditures | -60.12M |
| Depreciation & Amortization | 98.44M |
| Net Borrowing | -4.65M |
| Free Cash Flow | 684.87M |
| FCF Per Share | $3.36 |
Margins
Gross margin is 56.02%, with operating and profit margins of 32.22% and 6.71%.
| Gross Margin | 56.02% |
| Operating Margin | 32.22% |
| Pretax Margin | 13.25% |
| Profit Margin | 6.71% |
| EBITDA Margin | 33.86% |
| EBIT Margin | 32.22% |
| FCF Margin | 11.39% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.21% |
| Shareholder Yield | -3.21% |
| Earnings Yield | 1.60% |
| FCF Yield | 2.76% |
Analyst Forecast
The average price target for Incyte is $131.50, which is 8.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $131.50 |
| Price Target Difference | 8.05% |
| Analyst Consensus | Buy |
| Analyst Count | 28 |
| Revenue Growth Forecast (3Y) | 8.66% |
| EPS Growth Forecast (3Y) | 10.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 1, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 10.03 and a Piotroski F-Score of 7.
| Altman Z-Score | 10.03 |
| Piotroski F-Score | 7 |